Preprint
Article

Multicomponent synthesis of 4-aryl-4,9-dihydro-1H-pyrazolo[3,4-b]quinolines using L-proline as a catalyst – does it really proceed?

Altmetrics

Downloads

106

Views

44

Comments

0

A peer-reviewed article of this preprint also exists.

Submitted:

04 October 2023

Posted:

05 October 2023

You are already at the latest version

Alerts
Abstract
Looking for effective synthetic methods for 1H-pyrazolo[3,4-b]quinolines preparation, we came across a procedure where in a three component reaction catalyzed by L-proline, 4-aryl-4,9-dihydro-1H-pyrazolo[3,4-b]quinolines are formed. These compounds can be easily oxidized to a fully aromatic system, which gave hope for a synthetic method that could replace e.g. Friedländer condensation, often used for this purpose, although severely limited by the availability of suitable substrates. However, after careful repetition of the procedures described in the publication, it turned out that the compounds described therein do not form at all. The actual compounds turned out to be 4,4-(phenylmethylene)-bis-(3-methyl-1-phenylpyrazol-5-oles). 4-Aryl-4,9-dihydro-1H-pyrazolo[3,4-b]quinolines were prepared by another method and used as standards to compare the products formed in the original procedure.
Keywords: 
Subject: Chemistry and Materials Science  -   Organic Chemistry

1. Introduction

In 1901, Richard Willstätter synthesized tropinone, a synthetic precursor to the tropane alkaloid atropine. Its application, not always in a positive aspect, dates back to ancient times and is currently used, among others, in ophthalmology and as an antidote in case of organophosphate or organophosphorus compounds poisoning, e.g. parathion, tabun or sarin. The aforementioned tropinone was obtained in a 21-step synthesis from cyclopentanone with an overall yield of 0.75% [1] Hence, from a practical point of view, this reaction is basically useless. The opposite of this synthesis is the work published in 1917 by Robert Robinson, who obtained the mentioned tropinone in a one-step, three-component reaction with a yield of 17% [2]. This synthesis is one of the pioneering multicomponent chemical reactions. Earlier reactions of this type include Strecker’s synthesis of amino acids from aldehydes, ammonia and hydrogen cyanide published in 1854, or the slightly later Mannich reaction [3,4]. Almost 150 years have passed since then and multi-component reactions have entered the canon of organic synthesis and have been used, among others, in for obtaining biologically active systems. The subject of multicomponent syntheses has been discussed in numerous reviews and is also presented in many monographs [5,6,7,8]. The 1H-pyrazolo[3,4-b]quinoline, which is the subject of research in the current publication, can also be obtained using multi-component reactions. Only some of them will be mentioned, because an exhaustive discussion of this topic was made in a review covering the last 100 years of syntheses of this nitrogen heterocyclic system [9]. The first reaction of this kind was described in 1998 by Hormanza et al. (Scheme 1) [10].
Scheme 1. The first three component synthesis of 1H-pyrazolo[3,4-b]quinolines.
Scheme 1. The first three component synthesis of 1H-pyrazolo[3,4-b]quinolines.
Preprints 86963 sch001
They used 1,3-disubstituted 5-aminopyrazole 1 , aromatic aldehyde 2, and dimedone 3 for this purpose. During boiling in ethanol, formation of the corresponding 1H-pyrazolo[3,4-b]quinoline 4 was observed, in which both the carbocyclic ring and the middle one were not aromatic. Another important multicomponent reaction leading to 4-aryl-1H-pyrazolo[3,4-b]quinolines 7 is the procedure described by Tomasik et al. [11]. The authors used substituted anilines 5, aromatic aldehyde 2 and 2,5-diphenyl-2,4-dihydro-3H-pyrazol-5-one (6a, R1,3 = Ph) or 2-phenyl-5-methyl-2,4-dihydro-3H-pyrazol-3-one (6b, R1 = Ph, R2 = Me) (Scheme 2).
Scheme 2. The three component synthesis of fully aromatic 1H-pyrazolo[3,4-b]quinolines.
Scheme 2. The three component synthesis of fully aromatic 1H-pyrazolo[3,4-b]quinolines.
Preprints 86963 sch002
In this case a fully aromatic product is obtained. The reported yields, however, did not exceed 33% and even less when aniline was used. In the last case the final yields were less than 20%. The authors of the publication did not investigate the mechanism of formation of pyrazoloquinoline 7, which takes place in the case of this reaction. Product 7 was easily isolated by treating the reaction mixture with methanol and sonicating the whole. Besides 7 benzal derivative 8 was also isolated. At present, this is the only example of this type of multicomponent reaction where 1H-pyrazolo[3,4-b]quinoline 7 system is formed. In other cases, compounds with an aromatic pyridine ring and a saturated carbocyclic system are obtained. An example of such a reaction is shown in Scheme 3, where 5-amino-3-methyl-1-phenylpyrazole 9, 2-hydroxy-1,4-naphthalenedione 10 and aromatic aldehyde 2 were used. The reaction was carried out in the presence of an ionic liquid and PEG1000 and led to formation derivatives 11 [12,13].
Scheme 3. The three component synthesis of 1H-pyrazolo[3,4-b]quinolines with aromatic pyridine moiety.
Scheme 3. The three component synthesis of 1H-pyrazolo[3,4-b]quinolines with aromatic pyridine moiety.
Preprints 86963 sch003
In recent years, many multi-component reactions using L-proline as a catalyst have been described. These reactions, carried out under mild conditions, using water or alcohol as a solvent, are used, among others, for the synthesis of heterocyclic systems [14,15,16,17]. In 2017, Hegde and Shetty published a paper "Facile one-pot multicomponent synthesis of 1H-pyrazolo[3,4-b]quinolines using L-proline as a catalyst" in the Chemistry of Heterocyclic Compounds [18]. They used a three-component mixture of aniline 5a, aromatic aldehyde 2/12, 2-phenyl-5-methyl-2,4-dihydro-3H-pyrazol-3-one 6b and L-proline as a catalyst. The reaction was carried out in a boiling alcohol for 3-5 hours (Scheme 4).
Scheme 4. The potential synthesis of 4-aryl-4,9-dihydro-1H-pyrazolo[3,4-b]quinolines 13.
Scheme 4. The potential synthesis of 4-aryl-4,9-dihydro-1H-pyrazolo[3,4-b]quinolines 13.
Preprints 86963 sch004
The aforementioned publication describes a series of eight 4-aryl-4,9-dihydro-3-methyl-1-phenyl-1H-pyrazolo[3,4-b]quinolines 13a-f, h, i with an aromatic carbocyclic ring and two with a heterocyclic 13g, j in the 4-position, which has not been found in the reactions reported so far. The final yields were also relatively high, reaching 78-89%.

2. Results and Discussion

The reaction published in the paper by Hedge and Shetty seemed to us very interesting because the obtained compounds 13 can be oxidized to give fully aromatic systems 7 (Scheme 5).
Scheme 5. Potential oxidative aromatization of 4-aryl-4,9-dihydro-1H-pyrazolo[3,4-b]quinolines.
Scheme 5. Potential oxidative aromatization of 4-aryl-4,9-dihydro-1H-pyrazolo[3,4-b]quinolines.
Preprints 86963 sch005
An example of such reaction is the oxidation of pyrazolines to pyrazoles, which can be performed e.g. with oxygen in acetic acid, manganese(IV) oxide, DDQ or other oxidants [19,20,21]. Moreover, it can be expected that the overall yield could be greater than 33%, which is a serious shortcoming of the previous reaction described by Tomasik, especially in the case of aniline. For this reason, the reactions presented in Scheme 4 were very interesting to us and we decided to use their potential when it comes to the synthesis of fully aromatic 1H-pyrazolo[3,4-b]quinolines. The target was fluorescent sensors based on 1H-pyrazolo[3,4-b]quinolines substituted with a phenyl group in the 4-position. In 2001, Rettig and co-workers studied such sensors in which an aza-crown unit was used attached to the pyrazoloquinoline backbone through the phenyl group in position 4 [22]. 4-Aryl substituted pyrazolo[3,4-b]quinolines 7 can be synthesized using the Friedländer condensation of the corresponding o-aminobenzophenone and pyrazolone [23]. However, this route is out of the question for the synthesis of Rettig’s sensors due to problems with the preparation of the corresponding o-aminobenzophenone attached to aza-crown moiety. Also, the conditions under which the Friedländer condensation is carried out in the case of 1H-pyrazolo[3,4-b]quinolines could lead to partial decomposition of the final compound. The reaction described by Tomasik et al is not suitable for preparing compounds in which the phenyl ring in the 4-position is substituted with amino groups. For this reason, the three-component reaction catalysed with L-proline and subsequent oxidation offered hope for potential success. Before it was decided to use appropriate aldehydes with chelating units, we selectively checked the results published by Hegde and Shetty. p-Tolualdehyde 2a, p-chlorobenzaldehyde 2b and 2,4-dichlorobenzaldehyde 2e were selected for the tests. We chose these three compounds, among others, because the authors included spectra data of resulted 4,9-dihydro-1H-pyrazolo[3,4-b]quinolines 13a,b,e in supplementary materials in the form of graphics. In the publication, the reaction was carried out on a scale of 1 mmol and after its completion the reaction mixture was poured into ice water, the resulted precipitate was filtered off and crystallized from ethyl acetate. In our case, we increased the scale to 5 mmol to facilitate the isolation procedure of the final product. We also noticed that after a few minutes of heating, precipitation occurs in the three pilot reactions mentioned above. The authors of the publication do not mention this phenomenon in the experimental part. Isolating products in such a case is very easy and is limited to filtering the precipitate and standard crystallization to obtain product for basic analyses. The yields of resulted three products were high, so we hope to have sufficient amount of starting material for further oxidation. In order to confirm the structure of the molecules obtained, we performed 1H NMR and 13C NMR analyses. Unfortunately it turned out that the obtained compounds were not 4-aryl-4,9-dihydro-1H-pyrazolo[3,4-b]quinoline 13a,b,e derivatives at all. Instead, only 4,4’-(arylmethylene)-bis-(3-methyl-1-phenylpyrazol-5-oles 14a,b,e reaction products of an aromatic aldehyde 2 with two molecules of 5-methyl-2-phenyl-2,4-dihydro-3H-pyrazole-3-one 6b were isolated (Scheme 6). Unfortunately, exactly the same situation happened when we repeated the reaction with other aldehydes 2c,d,e,f,g. When p-hydroxybenzaldehyde 2h and 3,4-dimethoxybenzaldehyde 2i were reacted under the conditions described by Hegde and Shetty the orange precipitates 16a and 16b were isolated as products. Increasing the amount of solvent led to the formation of appropriate 4,4’-(arylmethylene)-bis-(3-methyl-1-phenylpyrazol-5-oles 14i and 14j again. In the case of 2-furylaldehyde, we were unable to isolate any products from the post-reaction mixture due to its tarnation, even though we used freshly purified aldehyde. In addition, in the case of p-tolualdehyde, Schiff’s base 15 (Ar = C6H4Me) was isolated from the post-reaction mixture. The compound was identified by comparison with a separately synthesized Schiff base prepared from aniline and p-tolualdehyde [24]. Appropriate Schiff bases were also detected with TLC in the post-reaction mixtures in the other two cases. The reactions were carried out exactly according to the procedures described in the publication, and also modified by extending the heating time to 24 hours with the same result. What is more interesting, when we carried out these reactions without the use of L-proline, we obtained exactly the same products 14. So there is a clear conclusion that L-proline has no part in this reaction and certainly does not contribute to the formation of 4-aryl-4,9-dihydro-1H-pyrazolol[3,4-b]quinoline 13 at all. In the original publication, the authors proposed a potential mechanism for this reaction, with emphasis on the role of L-proline forming an enamine with 2-phenyl-5-methyl-2,4-dihydro-3H-pyrazol-3-one 6b at the first step. In the next turn the formed enamine reacts with an aldehyde and aniline at last leading to 13. To finally remove any doubts about the product obtained by Hegde and Shetty, we performed additional syntheses by heating the pyrazolone 6b and a few aldehydes namely 2a, 2i and 2j in a 2:1 molar ratio. The obtained compounds are known and described in the literature, hence there are no doubts about their structure. When we compared the Rf values of the products obtained in the reaction with L-proline, without L-proline and without aniline using TLC chromatography, it turned out that they were identical. In conclusion, 4-aryl-4,9-dihydro-1H-pyrazolo[3,4-b]quinolines 13a/b were not formed in a three component reaction at all even though data from elemental analyzes and one based on MS spectra for 13b indicate this.
Scheme 6. The synthesis of 4,4’-(arylmethylene)-bis-(3-methyl-1-phenylpyrazol-5-oles) 14.
Scheme 6. The synthesis of 4,4’-(arylmethylene)-bis-(3-methyl-1-phenylpyrazol-5-oles) 14.
Preprints 86963 sch006
In the reactions depicted in Scheme 6 red-orange 4-arylidene systems 16 are formed in the initial stage. These compounds disappear during the course of the reaction and are present in trace amounts in the post-reaction mixture (comparison by TLC with original samples of 16). As the reaction proceeds, the corresponding 4,4’-(arylmethylene)-bis-(3-methyl-1-phenylpyrazol-5-ols) 14 precipitates in majority of cases or after the cooling in the refrigerator. As mentioned earlier the two exceptions were reactions with p-hydroxybenzaldehyde 2i and 3,4-dimethoxybenzaldehyde 2j, where instead of product 14, 4-benzylidene derivatives 16 a/b were obtained. They were formed at the very beginning of the reaction and did not disappear up to the end of heating. The disussion concerning the mechanism of this reaction can be found in the paper written by Hennig et al. [25] If we analyze the 1H NMR spectra included in the publication of Hegde and Shetty, they have a common element, namely peaks in the range of 14.00-13.00 and approximately at 5 ppm. The authors attribute the first of them to the proton bounded to nitrogen in position 9 and the second one to the methine proton at carbon C-4. The collected data are included in Table 1. We have also included some 1H NMR data for the derivatives 14 collected on the basis of some literature resources [26,27,28]. An example of such a publication is the work of Mohammadi and Ghorbani-Choghamarani who synthesized 14 (R= 4-Me, 4-Cl) using magnetic nanocomposites modified with sulfone groups [29]. If we take into account the 1H NMR shift values of protons attached to nitrogen in position 9 for p-tolubenzaldehyde and p-chlorobenzaldehyde derivatives 13, they are 14.00 and 13.90 ppm, respectively [18]. The corresponding shift values of the methine protons at the C-4 position are 4.89 ppm and 4.96 ppm. When we compare these values with the data published in Mohammadi and Ghorani-Choghamarani paper, we notice that they are almost identical, except that the values at the 13.94 ppm and 13.89 ppm correspond to protons attached to oxygen atoms of 14 and not nitrogen N-9 atoms in 13. In the 1H NMR spectra included in the work by Hegde and Shetty, one can also notice very weak broad peaks in the region of 12-13 ppm, which are identical to the peaks at 12.44 and 12.53 ppm coming from hydrogens associated with oxygen. In some derivatives 14 these peaks are not always visible.
Table 1. 1H NMR data of 4-aryl-4,9-dihydro-1H-pyrazolo[3,4-b]quinolines 13 and 4,4’-(arylenemethylene)-bis-(3-methyl-1-phenyl-pyrazol-5-oles) 14.
Table 1. 1H NMR data of 4-aryl-4,9-dihydro-1H-pyrazolo[3,4-b]quinolines 13 and 4,4’-(arylenemethylene)-bis-(3-methyl-1-phenyl-pyrazol-5-oles) 14.
Ar 4-Aryl-4,9-dihydro-1H-pyrazolo[3,4-b]quinoline 13 [18] 4,4’-(Arylenemethylene)-bis-(3-methyl-1-phenyl-pyrazol-5-ol) 14
N-H C-H O-H C-H
MeC6H4- 14.00 4.89 13.94; 12.44 4.92 [29]
ClC6H4- 13.90 4.96 13.89; 12.53 4.98 [29]
FC6H4- 13.92 4.77 13.70 4.94 [26]
MeOC6H4- 13.92 4.96 13.89 5.09 [26]
2,4-ClC6H3- 13.93 5.09 13.95; 12.67 5.05 [32]
NO2C6H4- 13.03 4.96 13.90; 12.49 5.14 [32]
3,4-OMeC6H3- 13.92 4.89 14.11; 11.68 4.91 [28]
4-OHC6H4 13.92 4.98 13.96; 12.2 4.86 [27]
Thiophen-2-yl 13.91 4.96 14.01; 12.51 5.14 [29]
Furan-2-yl 13.89 4.96 13.24 5.01 [26]
In the Figure 1 we included a 1H NMR spectrum of 4,4’-(4-chlorophenylmethylene)-bis-(3-methyl-1-phenyl-pyrazol-5-ole) 14b and these two peaks can be seen.
Figure 1. 1H NMR spectra of 4,4’-(4-chlorophenylmethylene)-bis-(3-methyl-1-phenylpyrazol-5-ol) 14b.
Figure 1. 1H NMR spectra of 4,4’-(4-chlorophenylmethylene)-bis-(3-methyl-1-phenylpyrazol-5-ol) 14b.
Preprints 86963 g001
In the case of the derivative obtained from p-chlorobenzaldehyde, the authors included the result of a measurement of mass spectrum (ESI) of the sample, obtaining values for [M+] 371 (100%), which corresponds to the structure of 4,9-dihydro-1-H-pyrazolo[3,4-b]quinoline 13a (R = Cl). Elemental analysis also confirms this structure. However, the 1H NMR spectrum indicates that in fact product 14b was formed. Unfortunately, we do not know where this inaccuracy came from. Another problem occurs in the case of a product obtained from p-tolualdehyde 2a. The 1H NMR spectra is depicted in Figure 2.
Figure 2. 1H NMR spectra of 4,4’-(4-methylphenylmethylene)-bis-(3-methyl-1-phenylpyrazol-5-ol) 14a.
Figure 2. 1H NMR spectra of 4,4’-(4-methylphenylmethylene)-bis-(3-methyl-1-phenylpyrazol-5-ol) 14a.
Preprints 86963 g002
In the case of the 1H NMR spectrum of alleged 4-(p-methylphenyl)-4,9-dihydro-3-methyl-1-phenyl-1H-pyrazolo[3,4-b]quinoline 13a (R = Me) the authors assigned each of the peaks located at 2.24 and 2.30 ppm respectively to three protons from methyl groups in each case. In fact, if we look closer at the 1H NMR spectrum for 14a, the ratio of the number of protons at 2.27 and 2.21 is 2:1. The same can be observed in publication of Mohammadi and Ghorbani-Choghamarani [29]. The spectra from publication of Hedge and Shetty are identical to those we obtained and the analysed compound cannot be 4-(p-methylphenyl)-1-phenyl-3-methyl-4,9-dihydro-1H-pyrazolo[3,4-b]quinoline 13a though elemental analysis confirm the molecular structure.
Based on our results, we can conclude that the three-component reaction of aniline 5a, aromatic aldehydes 2a-j, 2-phenyl-5-methyl-2,4-dihydro-3H-pyrazol-3-one 6b and a catalytic amount of L-proline is completely useless when it comes to the synthesis of 4-aryl-4,9-dihydro-1H-pyrazolo[3,4-b]quinolines 13. The question arises whether the previously mentioned structures 13 can be synthesized.
A different approach was used to check this. In 1911, Michaelis described the synthesis of 4-benzylidene-5-N-phenylaminopyrazoles 20 by reacting aromatic aldehydes 2 with 5-N-phenyl-3-methyl-1-phenylpyrazole 19 (Scheme 7) [30]. The author reported in the publication that he obtained two derivatives of this kind. However, later research by Tomasik et al. showed that the actual products formed in this reaction were 1H-pyrazolo[3,4-b]quinolines 7 [31].
Scheme 7. Cyclisation of 5-N-phenyl-3-methyl-1-phenylpyrazole to 4-aryl-4,9-dihydro-1H-pyrazolo[3,4-b]quinolines.
Scheme 7. Cyclisation of 5-N-phenyl-3-methyl-1-phenylpyrazole to 4-aryl-4,9-dihydro-1H-pyrazolo[3,4-b]quinolines.
Preprints 86963 sch007
Michaelis and the authors of the later publication did not study the course of the reaction, but it can be expected that during it an intermediate products 13 can be formed and correspond to those described in the work of Hedge and Shetty. To test this hypothesis, the appropriate aminopyrazole 19 was synthesized from phenylhydrazine 18 and 3-oxo-N-phenylbutanethioamide 17. In the next turn it was reacted with aldehydes 2a, 2b, 2e and 2g in the presence of anhydrous zinc chloride. Michaelis and Tomasik and their co-workers carried out a melting reaction of aromatic aldehyde 2 with 5-N-phenylpyrazole 19 in an open flask. The final yields of pyrazolo[3,4-b]quinoline 7 were in the order of 40-50%. Slightly larger when using a microwave field. If it is assumed that the intermediate product in this reaction is the 4,9-dihydro-1H-pyrazolo[3,4-b]quinoline 13 , it can be assumed that the oxygen present in the air plays a significant role in the oxidation of this compound. In order to eliminate its influence, the reaction was carried out in closed ampoules for 6 hours. After the end of heating and analysis of the post-reaction mixture by TLC, the presence of three products was found, namely 4-aryl-1H-pyrazolo[3,4-b]quinoline 7a,b,e,g, 4-aryl-4,9-dihydro-1H-pyrazolo[3,4 -b]quinoline 13a,b, and 4,4’-(arylmethylene)-bis-[3-methyl-N,1-diphenyl-1H-pyrazol-5-amine] 22 (Scheme 8).
Scheme 8. The final products from Michaelis protocol.
Scheme 8. The final products from Michaelis protocol.
Preprints 86963 sch008
The yield of 1H-pyrazolo[3,4-b]quinoline was definitely lower (5-8%) than in the case of the reaction carried out under air condensation (as in the original work by Michaelis). Separation of the products was very troublesome due to the almost identical values Rf of starting 19 and resulted 4,9-dihydro-1H-pyrazolo[3,4-b]quinolines 13. The products were separated by pre-removal of 1H-pyrazolo[3,4-b]quinoline with with residual unreacted aldehyde, and then the column was developed using a mixture of toluene and ethyl acetate in a ratio of 3:0.1 with a gradual increase in the amount of ethyl acetate to 3:0.4.
We performed the reaction only for four aldehydes 2a,b,e,g because in the case of the other ones we were not able to separate final products 13 and 21 with a sufficient purity for analysis. In case of furfural 2j as the only result we received a black tar. Figure 3 shows the 1H NMR spectrum of 4-(4-methylphenyl)-1-phenyl-3-methyl-4,9-dihydro-1H-pyrazolo[3,4-b]quinoline 13a. The signals presented in the spectrum do not coincide at all with those that are included in the supplementary materials of Shetty and Gatta. The proton at N-9 is visible at 6.32 ppm instead of 14.00 ppm. Both protons at 6.32 ppm and 5.28 ppm disappear after oxidation of 13a when 1H-pyrazolo[3,4-b]quinoline 7a is formed (Figure 4).
Figure 3. 1H NMR spectra of 4-(4-methylphenyl)-4,9-dihydro-3-methyl-1-phenyl-1H-pyrazolo[3,4-b]quinoline 13a.
Figure 3. 1H NMR spectra of 4-(4-methylphenyl)-4,9-dihydro-3-methyl-1-phenyl-1H-pyrazolo[3,4-b]quinoline 13a.
Preprints 86963 g003
Figure 4. 1H NMR spectrum of 4-(4-methylphenyl)-3-methyl-1-phenyl-1H-pyrazolo[3,4-b]quinoline 7a.
Figure 4. 1H NMR spectrum of 4-(4-methylphenyl)-3-methyl-1-phenyl-1H-pyrazolo[3,4-b]quinoline 7a.
Preprints 86963 g004
After obtaining and establishing the structure, compounds 13a, 13b, 13e and 13g were used as TLC standards when the three-component reaction was repeated with L-proline as a catalyst. These products were not found. The compounds 13 obtained by us can be transformed into fully aromatic pyrazolo[3,4-b]quinolines but obtaining them in pure form is pointless, because they themselves undergo oxidation during the reaction, forming systems 7. Our goal was to synthesize them to check whether they are formed at all in the reaction we examined and establish the correct structure. Taking into account the experiments performed and the interpretation of the results, the issue of the synthesis of 4-aryl-4,9-dihydro-1H-pyrazolo[3,4-b]quinolines using a multi-component reaction remains a challenge.

3. Materials and Methods

3.1. Chemicals and Instruments

Chemicals and solvent were purchased from Aldrich/Merck and POCh (Polish chemical company) respectively. 1H NMR and 13C NMR spectra were recorded using Bruker Advance III (400 MHz) and Bruker Advance III (600 MHz) spectrometers (Jagiellonian University, Faculty of Chemistry). Elemental analysis was performed using the CHNS Vario MICRO Cube analyzer with electronic micro balance. Melting points were measured using a MEL-TEMP II cryometer (Agricultural University, Faculty of Food Chemistry). TLC chromatograms were visualized using a dual-band (254 and 365 nm) Spectroline UV lamp model ENF-260/FE. 70-230 mesh ASTM silica gel purchased from Merck KGaA was used as the stationary phase in the column chromatographic methods. 70-230 mesh ASTM (Activity Grade I) alumina was also purchased at Merck KGaA. Mass spectra were taken with a mass spectrometer coupled to a Shimadzu LCMS-8040 high performance liquid chromatograph (Jagiellonian University, Faculty of Chemistry).

3.2. Experimental Procedures

3.2.1. An Attempt at the Synthesis of 4-Aryl-1-phenyl-3-methyl-4,9-dihydro-1H-pyrazolo[3,4-b]quinolines via Three Component Reaction According to Hegde and Shetty Protocol

Procedure a) 865 mg (5 mmol) of 2-phenyl-5-methyl-2,4-dihydro-3H-pyrazol-3-one, 600 mg (5 mmol) p-tolualdehyde, 450 mg (5 mmol) mmol) aniline, 75 mg (20 mol%) L-proline and 10 cm3 ethanol were introduced into a round bottom flask (25 cm3) and placed in a heating block and boiled for 5 hrs under reflux condenser. After the end of heating, the reaction mixture was left for 24 hours in the refrigerator and the separated crystalline precipitate was filtered off. The filtrate was evaporated, the resulting oil was dissolved in chloroform and dried with anhydrous MgSO4. The chloroform was evaporated and the oil obtained was dissolved in petroleum ether (40/60) and chromatographed on a silica gel column. The solution was evaporated and the light yellow oil was left in the refrigerator to solidify.
Procedure b): 5 mmoles of substrates without L-proline were used in the reaction.
4,4’-(4-Methylphenylmethylene)-bis-(3-methyl-1-phenylpyrazol-5-ol) 14a
Procedure a: Colourless crystals, 820 mg, yield 72%, mp. 204-5 °C. Lit. 203-205 °C [32].
Procedure b: Colourless crystals, 880 mg, yield 78%, mp. 204-5 °C.
1H NMR (400 MHz, DMSO-d6,) δ, ppm (J, Hz): 7.67 (d, J = 7.7 Hz, 4H), 7.40 (t, J = 7.9 Hz, 4H), 7.20 (t, J = 7.3 Hz, 2H), 7.10 (d, J = 8.1 Hz, 2H), 7.04 (d, J = 8.1 Hz, 2H), 4.87 (s, 1H); 2.27 (s, 6H), 2.21 (s, 3H). 13C NMR (101 MHz, DMSO-d6) δ, ppm: 146.8, 139.7, 135.3, 129.5, 129.2, 127.6, 126.1, 121.0, 33.3, 21.1, 12.1.
4-Methyl-N-[(1E)-phenylmethylidene]aniline 15a
Pale yellow crystalline mass, 173 mg, yield 18%, mp. 40-42 °C. Lit. 40-41°C [24]. TLC testing (toluene:petroleum ether 40/60 ratio 1:1) showed the sample to have identical Rf values to the original Schiff base synthesized from aniline and p-tolualdehyde .
4,4’-(4-Chlorophenylmethylene)-bis-(3-methyl-1-phenylpyrazol-5-ol) 14b
Procedure a: Colourless crystals, 878 mg, 74 %, mp. 205-6 °C. Lit. 206-8 °C [33]
Procedure b: Colourless crystals, 950 mg, 80 %, mp. 205-6 °C.
1H NMR(400 MHz, CDCl3) δ, ppm (J, Hz): 13.90 (s, 1H), 7.71 (d, J = 7.6 Hz, 4H), 7.45 (t, J = 8.0 Hz, 4H), 7.34 (d, J = 8.6 Hz, 2H), 7.30 – 7.21 (m, 4H), 4.97 (s, 1H), 2.33 (s, 6H). 13C NMR(100 MHz, CDCl3) δ, ppm (J, Hz): 146.68, 141.63, 131.01, 129.59, 129.42, 129.38, 128.47, 121.02, 33.02, 12.06.
4,4’-(4-Fluorophenylmethylene)-bis-(3-methyl-1-phenylpyrazol-5-ol) 14c
Procedure a: Colourless crystals, 900mg, 79%, mp. 168-9 °C. Lit. 180-1 °C [33].
Procedure b: Colourless crystals, 980 mg, 86%, mp. 167-8 °C.
1H NMR (400 MHz, DMSO) δ, ppm (J, Hz): 13.95 (s, 1H), 7.72 (d, J = 7.7 Hz, 4H), 7.45 (t, J = 7.9 Hz, 4H), 7.31-7.23 (m, , 4H), 7.11 (t, J = 8.9 Hz, 4H), 4.97 (s, 1H), 2.33 (s, 6H).
4,4’-(4-Methoxyphenylmethylene)-bis-(3-methyl-1-phenylpyrazol-5-ol) 14d
Procedure a: Colourless crystals, 230 mg ( 2 mmol scale), yield 49%, mp. 167-169°C. Lit. 165-167 °C [33].
1HNMR (400 MHz, DMSO-d6) δ, ppm (J, Hz): 7.67 (d, J = 7,9 Hz, 4H), 7.40 (t, J = 7,6 Hz, 4H), 7.20 (t, J = 7,0 Hz, 2H), 7.12 (d, J = 8,3 Hz, 2H), 6.80 (d, J = 8,4 Hz, 2H), 4.86 (s, 1H), 4.86 (s, 3H), 2.27 (s, 6H). 13C NMR (100 MHz, DMSO-d6) δ, ppm (J, Hz): 158.04, 146.69, 134.45, 129.28, 128.70, 126.03, 121.03, 114.03, 55.52, 32.87, 11.73.
4,4’-(2,4-Dichlorophenylmethylene)-bis-(3-methyl-1-phenylpyrazol-5-ol) 14e
Procedure a: Colourless crystals, 1100 mg, yield 86%, p. 234-5 °C. Lit. 228-230 °C [31]
Procedure b: Colourless crystals, 1000 mg, yield 79%, p. 233-5 °C.
1H NMR(400 MHz, DMSO-d6,) δ, ppm (J, Hz): 13.83 (s, 1H), 7.76 (d, J = 8.5 Hz, 1H), 7.70 (d, J = 7.7 Hz, 4H), 7.55 (d, J = 2.2 Hz, 1H, 7.43 (dt, J = 8.9, 5.0 Hz, 5H 7.25 (t, J = 7.4 Hz, 2H), 5.10 (s, 1H), 2.29 (s, 6H). 13C NMR(100 MHz, DMSO-d6,) δ, ppm: 146.47, 138.93, 133.36, 132.12, 131.90, 129.39, 129.31, 127.45, 126.15, 121.07, 31.84, 12.28.
4,4’-(4-Nitrophenylmethylene)-bis-(3-methyl-1-phenylpyrazol-5-ol) 14f
Procedure a: Colourless crystals, 850 mg, yield 71%, mp. 234-5 °C. Lit. 228-230 °C [31]
Procedure b: Colourless crystals, 900 mg, 75%, mp. 233-4 °C.
1H NMR(400 MHz, DMSO-d6,) δ, ppm (J, Hz): 13.87 (s, 1H), 8.18 (d, J = 8.9 Hz, 2H), 7.71 (d, J = 7.6 Hz, 4H), 7.53 (d, J = 8.4 Hz, 2H), 7.45 (t, J = 8.0 Hz, 4H), 7.26 (t, J = 7.4 Hz, 2H), 5.14 (s, 1H), 2.36 (s, 6H).13C NMR(101 MHz, DMSO-d6,) δ, ppm : 150.78, 146.75, 146.38, 129.40, 129.08, 126.20, 123.80, 121.07, 33.64, 12.05.
4,4’-(2-Thienylmethylene)-bis-(3-methyl-1-phenylpyrazol-5-ol) 14g
Procedure a: Colourless crystals, 140 mg ( 2 mmol scale), 33%, mp. 187-189 °C. Lit. 189-190 °C [34].
Procedure b: Colourless crystals, 500mg ( 5 mmol scale), 45%, mp. 187-188 °C.
1H NMR (400 MHz, DMSO-d6,) δ, ppm (J, Hz): 7.67 (d, J = 8,6 Hz, 1,0 Hz, 4H), 7,41 (t, J = 8.0 Hz, 4H), 7.27-7.18 (m, 3H), 6,87 (dd, J = 5.1 Hz, 3.5Hz, 1H), 6.73-6.69 (m, 1H), 5.09 (s, 1H), 2.28 (s, 6H). 13C NMR (101MHz, DMSO-d6) δ, ppm: 148.06, 146.34, 129.48, 127.30, 126.22, 124.69, 124.59, 29.98, 12.05.
4,4’-(4-Hydroxyphenylmethylene)-bis-(3-methyl-1-phenylpyrazol-5-ol) 14h
The reaction was carried out on a 5 mmol scale using 30 ml of ethanol as a solvent.
Procedure a: Yellow crystals, 890 mg, yield 78%, mp. 158-160 °C. Lit. 153-155 °C [27].
Procedure b: Yellow crystals, 930 mg, yield 82%, mp. 158-159 °C.
1H NMR (400 MHz, DMSO-d6,) δ, ppm (J, Hz): 13.94 (s, 1H), 9.18 (s, 1H), 7.72 (d, J = 7.8 Hz, 4H), 7.45 (t, J = 7.9 Hz, 4H), 7.25 (t, J = 7.3 Hz, 2H), 7.06 (d, J = 8.5 Hz, 2H), 6.68 (d, J = 8.6 Hz, 2H), 4.86 (s, 1H), 2.31 (s, 6H). 13C NMR (101MHz, DMSO-d6) δ, ppm: 155.96, 146.64, 132.73, 129.36, 128.55, 125.96, 120.95, 115.31, 32.84, 12.09.
4,4’-(3,4-Dimethoxyphenylmethylene)-bis-(3-methyl-1-phenylpyrazol-5-ol) 14i
The reaction was carried out on a 5 mmol scale using 30 ml of ethanol as a solvent.
Procedure a: Colourless crystals, 1050 mg, 85%, mp. 208-9 °C. Lit. 194-196 °C [27].
Procedure b: Colourless crystals, 1100 mg, 89%, mp. 207-9 °C.
1H NMR (400 MHz, DMSO-d6,) δ, ppm (J, Hz): 14.02 (s, 1H), 12.39 (s, 1H), 7.71 (d, J = 7.7 Hz, 4H), 7.45 (t, J = 7.9 Hz, 4H), 7.25 (t, J = 7.3 Hz, 2H), 6.85 (ddd, J = 17.9, 8.6, 1.6 Hz, 3H), 4.89 (s, 1H), 3.71 (s, 1H), 3.66 (s, 1H), 2.32 (s, 6H). 13C NMR (101MHz, DMSO-d6) δ, ppm: 148.86, 147.70, 146.63, 135.42, 129.38, 121.05, 119.76, 112.23, 112.09, 56.02, 55.96, 33.38, 12.13.
4,4’-(2-Furylmethylene)-bis-(3-methyl-1-phenylpyrazol-5-ol) 14j
The compound could not be isolated from the post-reaction mixture, but its presence was detected using TLC and compared with the original substance obtained in the reaction of pyrazolone 6b and 2-furylaldehyde.
(4E)-4-[(4-hydroxyphenyl)methylidene]-5-methyl-2-phenyl-2,4-dihydro-3H-pyrazol-3-one 16a
Procedure a: Orange crystals, 970 mg, yield 69%, mp. 239-240 °C. Lit. 238 °C [35]
1H NMR (600 MHz, DMSO) δ, ppm (J, Hz): 10.84 (s, 1H), 8.64 (d, J = 8.8 Hz, 2H), 7.93 (d, J = 7.6 Hz, 2H), 7.70 (s, 1H), 7.45 – 7.40 (m, 2H), 7.18 (t, J = 7.4 Hz, 1H), 6.95 (d, J = 8.9 Hz, 2H), 2.32 (s, 3H).
(4E)-4-[(3,4-dimethoxyphenyl)methylidene]-5-methyl-2-phenyl-2,4-dihydro-3H-pyrazol-3-one 16b
Procedure a: Orange crystals, 1230 mg, yield 76%, mp. 165-6 °C.
1H NMR (600 MHz, CDCl3) δ, ppm (J, Hz): 9.02 (s, 1H), 7.97 (d, J = 7.6 Hz, 2H), 7.71 (dd, J = 8.5, 2.0 Hz, 1H), 7.45 – 7.41 (m, 2H), 7.32 (s, 1H), 7.20 (t, J = 7.4 Hz, 1H), 6.96 (d, J = 8.4 Hz, 1H), 4.06 (s, 3H), 3.99 (s, 3H), 2.35 (s, 3H).
Calcd for: C19H18N2O3 C 70.79; H 5.63; N 8.69 Found 70.63; H 5.46; N 8.48.

3.2.2. A Synthesis of Selected 4,4’-(4-Arylmethylene)-bis-(3-methyl-1-phenylpyrazol-5-oles) from Aldehydes 2 and 5-Methyl-2-phenyl-2,4-dihydro-3H-pyrazole-3-one 6b - General Procedure

4,4’-(4-Methylphenylmethylene)-bis-(3-methyl-1-phenylpyrazol-5-ol) 14a
A round-bottomed flask (50 mL) equipped with reflux condenser and magnetic stirring bar was charged with p-tolualdehyde (120 mg, 1 mmol), 5-methyl-2-phenyl-2,4-dihydro-3H-pyrazole -3-one (340 mg, 2 mmol) and ethanol (10 mL). The content was boiled for 5 hours. After a few minutes formation of light pink precipitate was observed. After cooling the precipitate was filtered off and crystallized from ethanol/DMF mixture.
Pale pink crystals, 350 mg, 77%, mp. 204-5 °C.
4,4’-(4-Hydroxyphenylmethylene)-bis-(3-methyl-1-phenylpyrazol-5-ol) 14h
After cooling the solution was evaporated and the resulted solid was crystallized from methanol. Light yellow crystals, 375 mg, 82%, mp. 158-160 °C. Lit. 153-155 °C [27].
4,4’-(3,4-Dimethoxyphenylmethylene)-bis-(3-methyl-1-phenylpyrazol-5-ol) 14i
Pale yellow crystals, 425 mg, 85%, mp. 208-9 °C.
4,4’-(2-Furylmethylene)-bis-(3-methyl-1-phenylpyrazol-5-ol) 14j
Colourless crystals, 278mg, 65%, mp. 187-189 °C. Lit. 188-189 °C [26].
1H NMR (400 MHz, DMSO-d6,) δ, ppm (J, Hz): 13.85 (s, 1H), 7.72 (d, J = 7.7 Hz, 4H), 7.51 (s, 1H), 7.45 (t, J = 7.9 Hz, 4H), 7.26 (t, J = 7.4 Hz, 2H), 6.35 (dd, J = 3.1, 1.9 Hz, 1H), 6.13 (d, J = 3.2 Hz, 1H), 4.99 (s, 1H), 2.31 (s, 6H).13C NMR (101MHz, DMSO-d6) δ, ppm: 154.59, 146.42, 142.01, 129.38, 126.06, 121.02, 110.83, 106.60, 28.73, 11.96.

3.2.3. Synthesis of 4-Aryl-4,9H-dihydro-3-methyl-1-phenyl-1H-pyrazolo[3,4-b]quinolines by Cyclisation of 3-Methyl-N,1-diphenyl-1H-pyrazol-5-amine 20 with Aldehydes 2

3-Oxo-N-phenylbutanethioamide 18
The compound was prepared according to literature procedure [36].
3-Methyl-N,1-diphenyl-1H-pyrazol-5-amine 20
In a round bottom flask (100 cm3) were placed 6.7 g (0.035 mol) of 3-oxo-N-phenylbutanethiamide, 4 g (0.037 mol) of phenylhydrazine and 20 cm3 of glacial acetic acid. The mixture was refluxed for 12 hours until the evolution of hydrogen sulfide ceased. The acetic acid was evaporated and the resulting oil was treated with 10% NaHCO3. The mixture was extracted with methylene chloride. The organic layer was dried with anhydrous MgSO4. After removal of the sulfate, the solution was passed through a layer of alumina, evaporated and crystallized from toluene and petroleum ether with small amount of charcoal to decolorize final product. 6.74 g (77%) of light yellow crystals were obtained. M.p. 119-120 °C. Lit. 120 °C, 122-3 °C [37,38].
A glass vial (10 mL) equipped with magnetic stirring bar was charged with anhydrous zinc chloride (200mg, 1.5 mmol), p-tolualdehyde 2a ( 180mg, 1.5 mmol) and 20 (380 mg, 1.5 mmol). The vial was closed with with an air condenser and inserted into aluminum heating block and heated at 125 °C for 6 hours with stirring. After cooling the melt was digested with ethanol, sonicated and filtered of to remove pyrazolo[3,4-b]quinoline 7a. A filtrate was evaporated and the resulted oil was dissolved in toluene and chromatographed on column packed with silica gel (Merck 60, 70-230 mesh) using toluene – ethyl acetate mixture as eluent (toluene: AcOEt/ 3:0.1 →3:0.4) to separate 13a from 22a. The experiment was performed in two-fold way – in an open vial and with a closed vial.
4-(4-Methylphenyl)-3-methyl-1-phenyl-1H-pyrazolo[3,4-b]quinoline 7a
Yellow crystals, 150 mg, 26.7% (an open vial), 35 mg, 6.3% (a closed vial), mp. 208-210 °C. Lit. 206-207°C [11].
1H NMR(400 MHz, CDCl3) δ, ppm (J, Hz): 8.55 (d, J = 7.7 Hz, 2H), 8.23 (d, J = 8.1 Hz, 1H), 7.77 (t, J = 7.7 Hz, 4H), 7.59 (dd, J = 8.4, 7.6 Hz, 4H), 7.40 (dt, J = 13.7, 8.1 Hz, 5H), 7.31 (t, J = 7.4 Hz, 1H), 2.56 (s, 3H), 2.20 (s, 3H). 13C NMR (101 MHz, CDCl3) δ, ppm: δ 150.18, 148.49, 144.76, 143.97, 140.02, 138.62, 131.93, 130.25, 129.64, 129.03, 128.94, 127.06, 124.88, 123.81, 120.33, 116.46, 21.46, 15.07.
4-(4-Methylphenyl)-4,9-dihydro-3-methyl-1-phenyl-1H-pyrazolo[3,4-b]quinoline 13a
Colourless crystals, 67 mg, 11.6 % (open vial), 174 mg, 30,1% (closed vial), m.p. 178-180 °C.
1H NMR(400 MHz, CDCl3) δ, ppm (J, Hz): 7.60-7.54(m, 2H); 7.54-7.47(m, 2H); 7.34(t, J = 7.3 MHz, 1H), 7,15(d, J = 8.1Hz, 2H); 6.86-6.79(m, 1H); 6.74(dd, J = 8.4; 0.9Hz, 1H); 6.29 (s, 1H, N-H), 5.29(s, 1H), 2.31(s, 3H); 1.95(s, 3H). 13C NMR(100 MHz, CDCl3) δ, ppm : 147.72; 144.35; 138.58; 138.55, 137.20; 135.95; 131.32; 129.90, 129.33; 128.23; 127.25; 126.98; 125.00; 122.79; 122.13; 115.90; 100.77; 42.06, 21.15, 12.66.
Calculated for C24H21N3 ESI (M + H+) = 352,1808. Measured: ESI(M+H+) = 352,20.
4,4’-(4-Metylphenylmethylene)-bis-[3-methyl-N,1-diphenyl-1H-pyrazol-5-amine] 22a
Colourless crystals, 218 mg (closed vial), 45 %, mp. 198-99 °C
1H NMR(400 MHz, CDCl3) δ, ppm (J, Hz): 7,45(d, J = 7.9Hz, 4H); 7.30-7.21(m, 5H); 7.16(t, J = 7.4Hz, 2H); 7.03-6.82(m, 7H); 6.66(t, J = 7.3Hz, 2H); 6.26(d, J = 7.8Hz, 4H); 5.18(s, 1H); 4.58(s, 2H), 2,24(s, 3H); 1,97(s, 6H). 13C NMR(101 MHz, CDCl3) δ, ppm: 148.33; 144.71; 139.07; 137.37; 136.09; 129.09; 128.89; 128.18; 126.68; 122.92; 119.62; 115.07; 113.91; 36.34 (CH-methylene); 21.06 (C6H4CH3); 13.94 (3-CH3).
Cald. for C40H36N6 : ESI (M+H+) = 601,3074. Measured : ESI (M+H+) = 601,35.
4-(p-Chlorophenyl)-1-phenyl-3-methyl-1H-pyrazolo[3,4-b]quinoline 7b
Yellow crystals, 32 mg, 5.4%, mp. 230-231°C. The sample was identified with original one prepared according to literature procedure [39].
4-(p-Chlorophenyl)-4,9-dihydro-1-phenyl-3-methyl-1H-pyrazolo[3,4-b]quinoline 13b
Pale yellow powder, 53 mg, 8.9%, m.p. 129-130 °C.
1H NMR(400 MHz, CDCl3) δ, ppm (J, Hz): 7.62-7.57(m, 2H); 7.57-7.49(m, 2H); 7.41-7.34(m, 1H); 7.32-7.26(m, 1H); 7.26-7.20(m, 1H); 7.15-7.07(m, 1H); 7.03(t, J = 7.5Hz, 1H); 6.91-6.83(m, 1H); 6.78(dd, J = 8.0Hz; 0.8Hz, 1H), 6.41(s, 1H, N-H); 5,34(s, 1H, C-H); 1,98(s, 3H, 3-CH3). 13C NMR(100 MHz, CDCl3) δ, ppm:147.42; 145.72; 138.52; 137.10; 132.16; 131.14; 129.82; 129.52; 128.48; 127.40; 126.98; 124.15; 122.69; 122.08, 115.89; 100.05; 41.11; 12.59.
Calcd for C23H18ClN3 C 74.29; H 4.88; N 11.30. Found C 74.03; H 4.56; N 11.18.
4,4’-(4-Chlorophenylmethylene)-bis-[3-methyl-N,1-diphenyl-1H-pyrazol-5-amine)] 22b
White powder, 222 mg, 44.5%, mp. 202-3 °C.
1H NMR(400 MHz, CDCl3) δ, ppm: 7.51-7.43(m, 4H); 7.31(t, J = 7.8Hz, 4H); 7.21(t, J = 7.4Hz, 2H); 7.10(d, J = 8.5Hz, 2H); 7.02(dd, J = 16.5Hz, 8.7Hz, 6H); 6,72(t, J = 7.4Hz, 2H); 6,29(d, J = 7.7Hz, 4H); 5,20(s, 1H); 4,59(s, 2H); 2,02(s, 6H). 13C NMR(100 MHz, CDCl3) δ, ppm :148.00; 144.58; 139.04; 138.83; 137.26; 132.21; 129.37; 129.07; 129.01; 128.55; 126.78; 122.92; 119.69; 114.66; 113.74; 36.21; 13.91.
Calcd for C39H33ClN6 C 75.41; H 5.35; N 13.53 Found C 75.32; H 5.23; N 13.48.
4-(2,4-Dichlorophenyl)-1-phenyl-3-methyl-1H-pyrazolo[3,4-b]quinoline 7e
In this procedure 300 mg of 20 and 210 mg of 2,4-dichlorobenzaldehyde were used for reaction.
Yellow crystals, 24 mg (closed vial), 4,9 %, m.p. 158-9 °C.
1H NMR(400 MHz, CDCl3) δ, ppm (J, Hz): 8,54(dd, J = 8.7; 1,1Hz, 2H); 8.26(d, J = 8.3Hz, 1H); 7.83-7.77(m, 1H); 7.72(d, J = 2.0 Hz, 1H); 7.62-7.50(m, 2H); 7.46-7.40(m, 1H), 7.38(d, J = 8.2Hz, 1H); 7.35-7.29(m, 1H); 2.22(s, 3H, 3-Me).13C NMR(100 MHz, CDCl3) δ, ppm: 150.13; 148.53; 143.17; 139.85; 139.55; 135.85; 134.73; 132.69; 132.14; 130.45; 129.73; 129.28; 129.06; 127.24; 126.00; 125.09; 124.55; 122.92; 120.33; 116.31; 14.17.
Calcd for C23H15Cl2N3 C 68,33; H 3.74; N 10.39. Found C 68.14; H 3.45; N 10.28.
4-(p-2,4-Dichlorophenyl)-4,9-dihydro-1-phenyl-3-methyl-1H-pyrazolo[3,4-b]quinoline 13e
Pale yellow crystals, 128 mg, 27%, m.p. 220-1°C.
1H NMR(400 MHz, CDCl3) δ, ppm: 7.62-7.57(m, 2H); 7.54(dd, J = 10.5Hz, 5.2Hz, 2H); 7,44(t, J = 1.1Hz, 1H); 7.41-7.35(m, 1H); 7.16(d, J = 1.1Hz, 2H); 7.14-7.09 (m, 1H); 7.08(d, J = 7.7Hz, 1H); 6.90-6.84(m, 1H); 6.78(dd, J = 8.0Hz, 0.8Hz, 1H); 6.42(s, 1H, N-H); 5.99(s, 1H, C-H); 1.97(s, 3H). 13C NMR(100 MHz, CDCl3) δ, ppm: 147.37; 143.43; 138.76; 138.42; 137.10; 132.76; 132.52; 132.43; 130.74; 129.83; 128.88; 128.11; 127.66; 127.03; 123.65; 122.48; 122.24; 115.90; 99.69; 36.85; 11.91.
Calcd for C23H17Cl2N3 C 67,99; H 4,22; N 10,34. C 67.81; H 4.08; N 10.17.
4-(Thienyl-2-ylo)-3-methyl-1-phenyl-1H-pyrazolo[3,4-b]quinoline 7d
Yellow crystals, 95 mg (closed vial), 17%, m.p. 141-2 °C.
1H NMR(400 MHz, CDCl3) δ, ppm (J, Hz): 8,48(dd, J = 8.7Hz, 1.1Hz, 2H); 8.17(d, J = 7.8Hz, 1H); 7,89(d, J = 8.6Hz, 1H); 7.77-7.71(m, 1H); 7.64(dd, J = 5.1Hz, 1.2Hz, 1H); 7.58-7.51(m, 2H); 7.43-7.38(m, 1H); 7.31-7.23(m, 3H), 2,3(s, 3H). 13C NMR(101 MHz, CDCl3) δ, ppm: 153.47; 146.80; 139.27; 139.17; 138.29; 130.89; 129.93; 127.76; 126.99; 126.82; 125.33; 124.10; 123.65; 123.06; 121.50; 117.28; 99.95; 36.85; 1267.
Calcd for: C21H15N3S C 73.87; H 4.43; N 12.31. Found C 73.57; H 4.28; N 12.18.
4-(Thienyl-2-ylo)-4,9-dihydro-3-methyl-1-phenyl-1H-pirazolo[3,4-b]quinoline 13g
Colourless crystals, 150 mg, 29 %, m.p. 274-6 °C.
1H NMR(400 MHz, CDCl3) δ, ppm: 9.02(s, 1H); 7.58-7.46(m, 4H); 7.32(t, J = 7.2Hz, 1H); 7.26(t, J = 7.5 Hz, 1H); 7.12(d, J = 7.6Hz, 1H); 7.04(d, J = 4.1Hz, 2H); 6.98(d, J = 4.1Hz, 1H); 6,88(dd, J = 5.0Hz, 3.5Hz, 1H); 6.83-6.75(m, 1H); 5.67(s, 1H); 1.90(s, 3H). 13C NMR(100 MHz, CDCl3) δ, ppm: 153.47; 146.80; 139.27; 139.17; 138.29; 130.89; 129.93; 127.76; 126.99; 126.82; 125.42; 124.10; 123.65; 123.06; 121.50; 117.28; 99.95; 36.85; 12.67.
Calculated for C21H15N3S: ESI(M+H+) = 344,1216. Measured: ESI(M+H+) = 344,10.

4. Conclusions

Multicomponent reactions are an extremely valuable tool in organic synthesis. For this reason, we were interested in a three-component reaction in which 4-aryl-4,9-dihydro-1H-pyrazolo[3,4-b]quinolines can be prepared readily available commercial components like aniline, aromatic aldehydes, 2-phenyl-5-methyl-2,4-dihydro-3H-pyrazol-3-one and a catalytic amount of L-proline. These compounds can be oxidized at a later stage to obtain fully aromatic systems. Unfortunately, we were unable to repeat the results described in the publication and obtain the expected systems so we cannot agree with the authors’ statement “In conclusion, a simple and efficient protocol for one-pot multicomponent synthesis of 1H-pyrazolo[3,4-b]quinolines using L-proline as a catalyst has been developmed” [18]. These ones have been prepared by a different method and compared with the samples obtained according to original protocol. It seems to us that the authors simply misinterpreted the data they obtained.

Supplementary Materials

The 1H NMR and 13C NMR data of investigated compounds are available online.

Author Contributions

A.D. writing-original draft preparation and final corretions; AD/MK-design the study, organic synthesis, data analysis; AG, T.U. Spectra analysis; E.P., K.M., O.H. – organic synthesis, sample preparations. All authors have read and agreed to the published version of the manuscript.

Funding

there was no external funding.

Conflicts of Interest

The authors declare no conflict of interest.

References

  1. Willstätter, R. III. Synthese des Tropans und Tropidins. Ann. Chem. Pharm. 1901, 317, 307–374. [Google Scholar] [CrossRef]
  2. Investigating a scientific legend: the tropinone synthesis of Sir Robert Robinson, F. R. S. Notes Rec. R. Soc. Lond. 1993, 47, 277–296. [CrossRef]
  3. Strecker, A. Ueber einen neuen aus Aldehyd - Ammoniak und Blausäure entstehenden Körper. Ann. Chem. Pharm. 1854, 91, 349–351. [Google Scholar] [CrossRef]
  4. Mannich, C.; Krösche, W. Ueber ein Kondensationsprodukt aus Formaldehyd, Ammoniak und Antipyrin. Arch. Pharm. Pharm. Med. Chem. 1912, 250, 647–667. [Google Scholar] [CrossRef]
  5. Jiang, B.; Rajale, T.; Wever, W.; Tu, S.-J.; Li, G. Multicomponent reactions for the synthesis of heterocycles. Chem. Asian J. 2010, 5, 2318–2335. [Google Scholar] [CrossRef]
  6. Graebin, C.S.; Ribeiro, F.V.; Rogério, K.R.; Kümmerle, A.E. Multicomponent Reactions for the Synthesis of Bioactive Compounds: A Review. Curr. Org. Synth. 2019, 16, 855–899. [Google Scholar] [CrossRef]
  7. Insuasty, D.; Castillo, J.; Becerra, D.; Rojas, H.; Abonia, R. Synthesis of Biologically Active Molecules through Multicomponent Reactions. Molecules 2020, 25. [Google Scholar] [CrossRef]
  8. Zhi, S.; Ma, X.; Zhang, W. Consecutive multicomponent reactions for the synthesis of complex molecules. Org. Biomol. Chem. 2019, 17, 7632–7650. [Google Scholar] [CrossRef]
  9. Danel, A.; Gondek, E.; Kucharek, M.; Szlachcic, P.; Gut, A. 1H-Pyrazolo3,4-bquinolines: Synthesis and Properties over 100 Years of Research. Molecules 2022, 27. [Google Scholar] [CrossRef]
  10. Quiroga, J.; Insuasty, B.; Hormaza, A.; Saitz, C.; Jullian, C. Synthesis of 4-aryl-4,7,8,9-tetrahydro-6H-pyrazolo[3,4- b ]quinolin-5-ones. Journal of Heterocyclic Chemistry 1998, 35, 575–578. [Google Scholar] [CrossRef]
  11. Chaczatrian, K.; Chaczatrian, G.; Danel, A.; Tomasik, P. A Facile Synthesis of 4-Aryl-1H-pyrazolo[3,4-b]quinolines. ChemInform 2004, 35. [Google Scholar] [CrossRef]
  12. Ren, Y.-M.; Jin, S.; Yan, H.-J.; Zhang, Z. PEG1000-Based Dicationic Acidic Ionic Liquid Catalyzed One-Pot Synthesis of 4-Aryl-3-Methyl-1-Phenyl-1H-Benzo[h]pyrazolo [3,4-b]quinoline-5,10-Diones via Multicomponent Reactions. Catalysts 2015, 5, 1649–1656. [Google Scholar] [CrossRef]
  13. Wu, L.-Q.; Dong, R.-Y.; Yang, C.-G.; Yan, F.-L. Synthesis of 4-Aryl-3-Methyl-1-Phenyl-1 H -Benzo[ h ]Pyrazolo[3,4- b ]Quinoline-5,10-diones Using Diammonium Hydrogen Phosphate as an Efficient and Versatile Catalyst in Water. Jnl Chinese Chemical Soc 2010, 57, 19–23. [Google Scholar] [CrossRef]
  14. Vachan, B.S.; Karuppasamy, M.; Vinoth, P.; Vivek Kumar, S.; Perumal, S.; Sridharan, V.; Menéndez, J.C. Proline and its Derivatives as Organocatalysts for Multi- Component Reactions in Aqueous Media: Synergic Pathways to the Green Synthesis of Heterocycles. Adv. Synth. Catal. 2020, 362, 87–110. [Google Scholar] [CrossRef]
  15. Patel, A.J.; Patel, V.C.; Dholakia, A.B.; Patel, D.S. L-Proline Catalyzed Synthesis of Heterocycles: A Review. Organic Preparations and Procedures International 2023, 1–27. [Google Scholar] [CrossRef]
  16. Gadkari, Y.U.; Shanbhag, R.D.; Telvekar, V.N. An Efficient One-Pot, Multicomponent Synthesis of 1, 3-Thiazolidin-4- Ones Using L-Proline as Catalyst in Water. LOC 2022, 19, 9–13. [Google Scholar] [CrossRef]
  17. Karamthulla, S.; Pal, S.; Parvin, T.; Choudhury, L.H. L-proline catalyzed multicomponent reactions: facile access to 2H-benzo[g]pyrazolo[3,4-b]quinoline-5,10(4H,11H)-dione derivatives. RSC Adv 2014, 4, 15319–15324. [Google Scholar] [CrossRef]
  18. Hegde, H.; Shetty, N.S. Facile one-pot multicomponent synthesis of 1H-pyrazolo[3,4-b]quinolines using L-proline as a catalyst. Chem Heterocycl Comp 2017, 53, 883–886. [Google Scholar] [CrossRef]
  19. Casadia, I.; Albuquerque, D.Y. de; Carmo Capiotto, A.d.; Pereira de Pereira, C.M.; Pizzuti, L. Oxidative Aromatization of Pyrazolines. Curr. Org. Synth. 2017, 14. [Google Scholar] [CrossRef]
  20. Jenkins, R.N.; Hinnant, G.M.; Bean, A.C.; Stephens, C.E. Aerobic aromatization of 1,3,5-triarylpyrazolines in open air and without catalyst. Arkivoc 2015, 2015, 347–353. [Google Scholar] [CrossRef]
  21. Nakamichi, N.; Kawashita, Y.; Hayashi, M. Oxidative aromatization of 1,3,5-trisubstituted pyrazolines and Hantzsch 1,4-dihydropyridines by Pd/C in acetic acid. Org. Lett. 2002, 4, 3955–3957. [Google Scholar] [CrossRef]
  22. Rurack, K.; Danel, A.; Rotkiewicz, K.; Grabka, D.; Spieles, M.; Rettig, W. 1,3-Diphenyl-1H-pyrazolo3,4-bquinoline: a versatile fluorophore for the design of brightly emissive molecular sensors. Org. Lett. 2002, 4, 4647–4650. [Google Scholar] [CrossRef] [PubMed]
  23. Tomasik, D.; Tomasik, P.; Abramovitch, R.A. Friedländer condensation of 1 H -pyrazolin-5-ones with O -aminobenzaldehydes. Synthesis of 1 H -pyrazolo[3,4- B ]quinolines. Journal of Heterocyclic Chemistry 1983, 20, 1539–1543. [Google Scholar] [CrossRef]
  24. Song, Q.-W.; Yu, B.; Liu, A.-H.; He, Y.; Yang, Z.-Z.; Diao, Z.-F.; Song, Q.-C.; Li, X.-D.; He, L.-N. PEG400-enhanced synthesis of gem-dichloroaziridines and gem-dichlorocyclopropanes via in situ generated dichlorocarbene. RSC Adv. 2013, 3, 19009. [Google Scholar] [CrossRef]
  25. Hennig, L.; Alva-Astudillo, M.; Mann, G.; Kappe, T. New aspects in the reaction of azomethines with cyclic CH-acidic compounds. Monatsh Chem 1992, 123, 571–579. [Google Scholar] [CrossRef]
  26. Phatangare, K.R.; Padalkar, V.S.; Gupta, V.D.; Patil, V.S.; Umape, P.G.; Sekar, N. Phosphomolybdic Acid: An Efficient and Recyclable Solid Acid Catalyst for the Synthesis of 4,4′-(Arylmethylene)bis(1H-pyrazol-5-ols). Synthetic Communications 2012, 42, 1349–1358. [Google Scholar] [CrossRef]
  27. Keshavarz, M.; Vafaei-Nezhad, M. Design and Characterization of l-Prolinate-Amberlite as a Novel Heterogeneous Organocatalyst and Its Catalytic Application in the Synthesis of Pyrazol-Derivates. Catal Lett 2016, 146, 353–363. [Google Scholar] [CrossRef]
  28. Tamoradi, T.; Mousavi, S.M.; Mohammadi, M. Synthesis of a new Ni complex supported on CoFe 2 O 4 and its application as an efficient and green catalyst for the synthesis of bis(pyrazolyl)methane and polyhydroquinoline derivatives. New J. Chem. 2020, 44, 8289–8302. [Google Scholar] [CrossRef]
  29. Mohammadi, M.; Ghorbani-Choghamarani, A. Hercynite silica sulfuric acid: a novel inorganic sulfurous solid acid catalyst for one-pot cascade organic transformations. RSC Adv 2022, 12, 26023–26041. [Google Scholar] [CrossRef]
  30. Michaelis, A. Über 5-Aminopyrazole und über Iminopyrine. I. Über substituierte 5-Iminopyrazolone und über 5-Aminopyrazole. Ann. Chem. Pharm. 1911, 385, 1–43. [Google Scholar] [CrossRef]
  31. Danel, A.; Chaczatrian, K.; Tomasik, P. Microwave-assisted, facile route to 1H-pyrazolo[3,4-b]quinolines. Arkivoc 2000, 2000, 51–57. [Google Scholar] [CrossRef]
  32. Eskandari, K.; Karami, B.; Khodabakhshi, S. An Unexpected Catalytic Synthesis of Novel and Known Bis(Pyrazolyl) Methanes by the use of α -aryl- N -phenyl Nitrones in Aqueous Media. Journal of Chemical Research 2014, 38, 600–603. [Google Scholar] [CrossRef]
  33. Keshavarz, M.; Zarei Ahmady, A.; Vaccaro, L.; Kardani, M. Non-Covalent Supported of l-Proline on Graphene Oxide/Fe₃O₄ Nanocomposite: A Novel, Highly Efficient and Superparamagnetically Separable Catalyst for the Synthesis of Bis-Pyrazole Derivatives. Molecules 2018, 23. [Google Scholar] [CrossRef] [PubMed]
  34. Gouda, M.A.; Al-Balawi, M.M.M.; Abu-Hashem, A.A. One-pot pseudo five-component synthesis and antioxidant evaluation of 4,4’-(aryl-methylene)bis(3-methyl-1-phenyl-1H-pyrazol-5-ol). Eur. J. Chem. 2016, 7, 363–367. [Google Scholar] [CrossRef]
  35. Thummar, B.B.; Tarpada, U.P.; Raval, D.K. Study on One-pot Biginelli-like Synthesis of Pyrazolo[3,4- d ]pyrimidines in Bronsted Acidic Ionic Liquid Under Sonication and its Mechanism. Journal of Heterocyclic Chemistry 2014, 51, 1740–1746. [Google Scholar] [CrossRef]
  36. Worrall, D.E. THE ADDITION OF 1,3-DIKETONES TO ISOTHIOCYANATES. I. ACETYLACETONE AND CERTAIN ARYL ISOTHIOCYANATES. J. Am. Chem. Soc. 1920, 42, 1055–1061. [Google Scholar] [CrossRef]
  37. Borisevich, A.N.; Pel’kis, P.S. Arylamides of substituted thioacetic acids. Chem Heterocycl Comp 1972, 5, 237–239. [Google Scholar] [CrossRef]
  38. Kucharek, M.; Danel, A. Palladium-catalyzed amino group arylation of 1,3-disubstituted 1H-pyrazol-5-amine based on Buchwald–Hartwig reaction. Chem Heterocycl Comp 2021, 57, 633–639. [Google Scholar] [CrossRef]
  39. Khachatryan, K.; Boszczyk, W.; Tomasik, P. Optical Properties of Some 4-Aryl-1H-pyrazolo[3,4-b]quinolines. ChemInform 2006, 37. [Google Scholar] [CrossRef]
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.
Copyright: This open access article is published under a Creative Commons CC BY 4.0 license, which permit the free download, distribution, and reuse, provided that the author and preprint are cited in any reuse.
Prerpints.org logo

Preprints.org is a free preprint server supported by MDPI in Basel, Switzerland.

Subscribe

© 2024 MDPI (Basel, Switzerland) unless otherwise stated